TrialDrug design, development and therapy2015

Pharmacokinetics, pharmacodynamics, and tolerability of LC350189, a novel xanthine oxidase inhibitor, in healthy subjects.

Seonghae Yoon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.